You are here

XPhyto Therapeutics Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
XPHY
CSE Index: 
Currency: 

XPhyto Therapeutics Corp. (“XPhyto”) is a diversified bioscience company with strategic assets and investments in the field of rapid pathogen screening systems and next generation drug delivery, as well as medical cannabis opportunities focused on emerging European markets. Through its 100% owned subsidiaries and exclusive development and commercialization agreements, XPhyto is pursuing clinical programs for the transdermal and dissolvable oral delivery of conventional and cannabis based therapeutics for neurological applications, as well as rapid dissolvable oral biosensor and lateral flow assay-based screening tests for dental health applications and high-risk pandemic threats such as COVID-19, H1N1 (swine flu) and H5N1 (avian flu).

You are here

XPhyto Therapeutics Corp. (XPHY)

SEDAR Information

Company Info

Address
Suite 270 - 1820 Fir Street
Vancouver, BC V7Y 1G5
Canada
Phone
780-818-6422
Email
info@xphyto.com
Listing date
Wednesday, July 31, 2019
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
58,010,145
Reserved for Issuance: 
24,540,357

Bulletins

30/07/2019

2019-0724 – New Listing - XPhyto Therapeutics Corp. (XPHY)

le 30 juillet/July 2019

The common shares of XPhyto Therapeutics Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2020-08-11_TechTues_MedicalDevices_Website

Tech Tuesdays

Tuesday, August 11, 2020 -
4:15pm to 5:00pm
08-12_Virtual_Industry_Updates_Whats_Next_for_the_Cannabis_Industry_Imagery_Website

Virtual Industry Updates: What's Next for the Cannabis Industry?

Wednesday, August 12, 2020 -
3:00pm to 4:15pm